Myofibroblastic Cancer-Associated Fibroblast Subtype Heterogeneity in Pancreatic Cancer

Scientists evaluated the gene and protein expression differences in two myofibroblastic cancer-associated fibroblast (CAF) lines using single-cell and bulk RNA-sequencing. They utilized proliferation and migration assays to determine the effect of different CAF lines on a tumor cell line.